ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Risk Management for Biotech Companies in Clinical Trials"
Episode Synopsis
In this episode, Alex Watt, Global Head for Biotech Integrated Laboratory Solutions and Alan Wookey, Global Head of Companion Diagnostics discuss how to manage both scientific and operational risk in clinical trials for biotech companies.
Looking at risk as uncertainty reveals not only threats to project timelines but also opportunities to take a new approach.
Alex and Alan talk about:
How different risks are evaluated and prioritized and the processes put in place to mitigate and/or respond to those risks if they occur.
What sponsors can do to reduce the risks for their study
How Q2 Solutions' in-house scientific and regulatory expertise ensure that your data are compliant to global regulations
You can learn more at https://q2labsolutions.com/biotech.
Looking at risk as uncertainty reveals not only threats to project timelines but also opportunities to take a new approach.
Alex and Alan talk about:
How different risks are evaluated and prioritized and the processes put in place to mitigate and/or respond to those risks if they occur.
What sponsors can do to reduce the risks for their study
How Q2 Solutions' in-house scientific and regulatory expertise ensure that your data are compliant to global regulations
You can learn more at https://q2labsolutions.com/biotech.
More episodes of the podcast Laboratory Considerations for Clinical Trials
Managing Sample Data from Vendors
14/09/2021
Automation within an ADME Laboratory
26/08/2021
Bioanalytical Automation of Samples
30/07/2021
Consent Tracking for Clinical Samples
28/07/2021
In God we trust